what-when-how
In Depth Tutorials and Information
[39]
Lapiere CM, Lenaers A, Kohn LD. Procollagen peptidase: an
enzyme excising the coordination peptides of procollagen. Proc
Natl Acad Sci USA 1971;68(12):3054-8.
[47]
Feshchenko S, Brinckmann J, Lehmann HW, Koch HG, Muller PK,
Kugler S. Identiication of a new heterozygous point mutation in
the COL1A2 gene leading to skipping of exon 9 in a patient with
joint laxity, hyperextensibility of skin and blue sclerae. Mutations
in brief no. 166. Online. Hum Mutat 1998;12(2):138.
[40]
Nusgens BV, Verellen-Dumoulin C, Hermanns-Le T, De Paepe A,
Nuytinck L, Pierard GE, et  al. Evidence for a relationship
between Ehlers-Danlos type VII C in humans and bovine
dermatosparaxis. Nat Genet 1992;1(3):214-7.
[48]
Kuivaniemi H, Sabol C, Tromp G, Sippola-Thiele M, Prockop DJA.
19-base pair deletion in the pro-alpha 2(I) gene of type I procolla-
gen that causes in-frame RNA splicing from exon 10 to exon 12 in
a proband with atypical osteogenesis imperfecta and in his asymp-
tomatic mother. J Biol Chem 1988;263(23):11407-13.
[41]
Smith LT, Wertelecki W, Milstone LM, Petty EM, Seashore MR,
Braverman IM, et  al. Human dermatosparaxis: a form of Ehlers-
Danlos syndrome that results from failure to remove the amino-
terminal propeptide of type I procollagen. Am J Hum Genet 1992;
51(2):235-44.
[49]
Nicholls AC, Oliver J, Renouf DV, Heath DA, Pope FM. The
molecular defect in a family with mild atypical osteogenesis
imperfecta and extreme joint hypermobility: exon skipping
caused by an 11-bp deletion from an intron in one COL1A2
allele. Hum Genet 1992;88(6):627-33.
[42]
Fujimoto A, Wilcox WR, Cohn DH. Clinical, morphological, and
biochemical phenotype of a new case of Ehlers-Danlos syn-
drome type VIIC. Am J Med Genet 1997;68(1):25-8.
[43]
Colige A, Sieron AL, Li SW, Schwarze U, Petty E, Wertelecki W,
et  al. Human Ehlers-Danlos syndrome type VII C and bovine
dermatosparaxis are caused by mutations in the procollagen I
N-proteinase gene. Am J Hum Genet 1999;65(2):308-17.
[50]
Raff ML, Craigen WJ, Smith LT, Keene DR, Byers PH. Partial
COL1A2 gene duplication produces features of osteogenesis
imperfecta and Ehlers-Danlos syndrome type VII. Hum Genet
2000;106(1):19-28.
[44]
Makareeva E, Cabral WA, Marini JC, Leikin S. Molecular mecha-
nism of alpha 1(I)-osteogenesis imperfecta/Ehlers-Danlos syn-
drome: unfolding of an N-anchor domain at the N-terminal end of
the type I collagen triple helix. J Biol Chem 2006;281(10):6463-70.
[51]
Sippola M, Kaffe S, Prockop DJ. A heterozygous defect for
structurally altered pro-alpha 2 chain of type I procolla-
gen in a mild variant of osteogenesis imperfecta. The altered
structure decreases the thermal stability of procollagen and
makes it resistant to procollagen N-proteinase. J Biol Chem
1984;259(22):14094-100.
[45]
Cabral WA, Makareeva E, Colige A, Letocha AD, Ty JM, Yeowell
HN, et al. Mutations near amino end of alpha1(I) collagen cause
combined osteogenesis imperfecta/Ehlers-Danlos syndrome by
interference with N-propeptide processing. J Biol Chem 2005;
280(19):19259-69.
[52]
Malfait F, Symoens S, Goemans N, Gyftodimou Y, Holmberg E,
López-González V, et  al. Helical mutations in Type I collagen
that affect the processing of the amino-propeptide result in an
Osteogenesis Imperfecta/Ehlers-Danlos syndrome overlap syn-
drome. Orphanet J Rare Dis 2013;8(1):78.
[46]
Dombrowski KE, Vogel BE, Prockop DJ. Mutations that alter the
primary structure of type I procollagen have long-range effects
on its cleavage by procollagen N-proteinase. Biochemistry
1989;28(17):7107-12.
Search WWH ::




Custom Search